Search
  • EVI

Training in vaccine research and development

3rd Call for TRANSVAC Training Modules now advertised.


The TRANSVAC2 Consortium has set up training modules at leading European centers that can be combined to create customised international courses on vaccine R&D. Two rounds of tailored training courses are planned. Participants can select topics as needed in their field of vaccine development and the timelines of the various modules are harmonized in a way that allows a logical continuation from one topic to the other. The third call is open from 20th December 2018 – 1st March 2019. It covers 2 modules:

M4: Validity and comparison of animal models Venue: Wageningen University (SWR)/ Lelystad, The Netherlands Date: 6 – 7 June 2019
M5: Statistics for Vaccine Evaluation Venue: Biomedical Primate Research Centre (BPRC)/Rijswijk, the Netherlands Date: 10 – 14 June 2019 

Deadline for applications: 1st  March 2019. Notification of application outcome: 1st  April 2019. Participants will be selected by a course selection panel. The course is offered free of charge. However selected applicants will have to cover their own travel, accommodation and visa expenses.

Candidates working in a European Union Member State or Associated Member State as well as candidates from other countries who are working in vaccine development projects funded by the European Commission (EC) or European and Developing Countries Clinical trial Partnership (EDCTP) are eligible to apply. Other candidates can also apply, but priority will be given to the groups mentioned above.

For more information about the training modules offered by TRANSVAC, the eligibility criteria and the application process, please visit: www.transvac.org. The application form can be found here. If you have any specific questions, you can contact the project management team at: transvacinfo@euvaccine.eu.

Recent Posts

See All

Join European Vaccine Initiative mailing list for updates on projects, training and funding opportunities

© 2020 European Vaccine Initiative. Designed by European Vaccine Initiative